JDS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Dairy Science Vol. 61 No. 5 665-668
© 1978 by American Dairy Science Association ®
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miller, C. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller, C. C.

Development, Manufacture, and Distribution of Animal Drugs

C. C. Miller

The Upjohn Company, Animal Health Research and Development, Kalamazoo, Ml 49001

ABSTRACT

Introduction

The key to wise use of drugs by the dairy producer is to follow directions of the label. Label directions are written by manufacturers, reviewed, and approved by the Food and Drug Administration in a manner consistent with the way it was researched. To deviate from label directions is an invitation to trouble with respect to both efficacy and safety of the product. To provide specifics, an example of the development of a mastitis preparation is presented. Hopefully, from this one will obtain a better understanding of why it is critical that products be used as labeled.

Formulation

Mastitis formulations which are infused intramammarily have unique requirements among parenterally used products. The formulation must be suitable as a carrier for the active drugs. It must be both chemically and physically stable. At the same time the formulation must not be so irritating to the udder that it creates more problems than it cures.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1978 by the American Dairy Science Association ®.